Other News

JenaValve Technology Appoints Keith D. Dawkins, M.D., as Board Member

IRVINE, Calif.–(BUSINESS WIRE)–JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member. “As JenaValve advances its clinical development […]

Global Transcatheter Aortic Valve Implantation (TAVI) Market Analysis & Outlook 2018-2022 with Profiles of Abbott Laboratories, Boston Scientific, Edwards Lifesciences & Medtronic – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. “Global TAVI Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market, with focus on the U.S and European markets. The global TAVI market is expected to grow in future due […]

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

VANCOUVER, March 23, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company“) (NASDAQ, TSX:NVCN) announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum market value requirement set forth in Nasdaq Rules […]

JenaValve Technology Appoints Keith D. Dawkins, M.D., as Board Member

IRVINE, Calif.–(BUSINESS WIRE)– JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member. “As JenaValve advances its clinical development […]

Philips provides University of Ottawa Heart Institute with innovative health technology solutions for their expanded cardiovascular care facility

AMSTERDAM, March 23, 2018 /CNW/ – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology has delivered a broad range of health technology solutions to the University of Ottawa Heart Institute (UOHI) – Canada’s largest and foremost heart health centre dedicated to understanding, treating, and preventing heart disease. Today, […]

Canon Medical Systems’ Premium Ultrasound Provides New and Unique Features for a Wide Range of Liver Analysis

TUSTIN, Calif.–(BUSINESS WIRE)– A robust suite of quantitative tools to assess the spectrum of liver disease (including Steatosis, Inflammation and Cirrhosis) on Canon Medical Systems U.S.A., Inc.’s premium AplioTM i800 ultrasound system received FDA clearance. The industry’s most comprehensive Liver Analysis Suite is available on the Aplio i800, and may be helpful in the […]

New Biocompatible Particle Embolic Device to Therapeutically Slow or Stop Blood Flow Presented at the 2018 Society of Interventional Radiology (SIR) Conference

LOS ANGELES–(BUSINESS WIRE)–A scientific presentation of a new vascular embolic device was presented today at the 2018 Society of Interventional Radiology conference in Los Angeles, California – GPX: A New Proprietary In Situ Setting Embolic Agent that Combines the Benefits of Coils, Gel-Beads, and Other Embolics. “GPX is a biocompatible particle embolic loaded in […]

Access Scientific, LLC Announces Discovery of the Cause of POWERWAND™ Catheters’ ZERO Bloodstream Infections in over 35,000 Catheter-Days of Published Use

SAN DIEGO–(BUSINESS WIRE)–Unprecedented. That’s what Access Scientific is calling the dramatic results from a leading biofilm laboratory that explain why the company’s POWERWAND™ midlines and extended-dwell catheters consistently report zero associated bloodstream infections (BSIs). Independent, peer-reviewed published studies and scientific posters on the company’s POWERWAND™ catheters – which now tally […]

LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, has announced the first patient enrollment in the Perceval® Valve Clinical study for Chinese Registration (“PERFECT”) Trial. The study is a pre-market, prospective, single-arm trial. The PERFECT trial is being conducted to demonstrate the safety and effectiveness of […]

Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe

IRVINE, Calif., March 21, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that enrollment is complete in the computed tomography (CT) imaging sub-study within the PARTNER 3 trial of the SAPIEN 3 valve. This randomized sub-study is examining […]